Subsequently, the mechanistic role of TPX2 in cancer progression and angiogenesis was investigated to determine whether TPX2 siRNA has therapeutic potential as a molecular targeting drug for pancreatic cancer. Here, TPX2 is linked to pancreatic neoplasm.